Rising hCG Levels in Vulvar Cancer Patients
Author Information
Author(s): HWA de Bruijn, KA ten Hoor, M Krans, AGJ van der Zee
Primary Institution: University Hospital Groningen
Hypothesis
The synthesis of the beta-subunit of hCG can be increased in vulvar carcinoma as the disease progresses.
Conclusion
Elevated serum levels of the beta-subunit of hCG were found in 50% of patients with recurrent vulvar carcinoma, indicating a potential marker for disease progression.
Supporting Evidence
- 50% of patients with locoregional recurrences or progressive vulvar carcinoma had elevated serum levels of the beta-subunit of hCG.
- At diagnosis, only 5% of patients had elevated serum levels of hCG.
- Rising serum levels were found in 7 of the 14 patients with recurrent disease.
Takeaway
Doctors found that some women with vulvar cancer have higher levels of a certain hormone when their cancer gets worse, which might help them understand how the disease is changing.
Methodology
Blood samples were taken from patients with vulvar cancer, and serum levels of the beta-subunit of hCG were measured using an enzyme immunoassay.
Limitations
The usefulness of hCG as a serum marker for following disease progression or identifying poor prognosis remains uncertain due to low detection rates at diagnosis.
Participant Demographics
Patients with vulvar malignancies referred to the University Hospital of Groningen, including those with newly diagnosed cancer and those with recurrent disease.
Statistical Information
P-Value
0.060
Want to read the original?
Access the complete publication on the publisher's website